Skip to Main Content
Services Talent Knowledge
Site Search
Menu

PressRelease

June 12, 2018

Elizabeth Betta Joins Barclay Damon as Associate

June 12, 2018—Barclay Damon announces the arrival of Elizabeth Betta, associate, to the firm's Buffalo office. Elizabeth is a member of the Commercial Litigation Practice Area.
Prior to joining Barclay Damon, Elizabeth was senior counsel at MERSCORP Holdings, Inc. and held associate positions at notable international firms Arnold & Porter LLP and Jones Day. She primarily focuses her practice on complex commercial disputes involving contracts, securities, antitrust, environmental, and other business issues.

Elizabeth graduated first in her class from American University Washington College of Law, where she was a member of the American University Law Review.

A leading Northeast firm made up of 275 attorneys, Barclay Damon LLP is the largest law firm based in Upstate New York. As a full-service law firm with experience in virtually every legal area clients may require, our attorneys team across practices to provide customized, targeted solutions informed by deep industry understanding. Barclay Damon has offices with 30 to 105 attorneys in Albany, Buffalo, Rochester, and Syracuse. The firm also has growing offices in Boston, New Jersey, New York City, New York State's Southern Tier, Toronto, and Washington DC. For more information, visit barclaydamon.com.

Subscribe

Click here to sign up for alerts, blog posts, and firm news.

Featured Media

Alerts

Massachusetts Federal Court Permits Sharing Clause in Protective Order in Products Liability Case

Alerts

NYS Court of Appeals Holds That Parent May Not Recover for Emotional Injuries in Prenatal-Injury Case

Alerts

Smarter Inventory Management for Pharmacies: Navigating Online Marketplace Compliance

Alerts

Emergency Wine Run, Now Legal: New York State Opens Retail-to-Retail Sales

Alerts

California's Updated Privacy Regulations: Automated Decisionmaking Technology, Cybersecurity Audits, and Risk Assessments, Part 1

Alerts

Pharmacies on High Alert: Optum Rx's 25-Percent Therapeutic-Class Cap Creates Major Legal, Operational, and Competitive Risks